Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Retrospective review of 0.05% and 0.01% atropine eye drops for suppressing myopia progression in school-age children
TCTR20220930002Completed
- Sponsor
- Faculty of Medicine Siriraj Hospital, Mahidol University
- Start
- Sep 2022
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label trial of atropine in myopia (2 arms), sponsored by Faculty of Medicine Siriraj Hospital, Mahidol University. Primary endpoints: Myopia progression and Safety of low-dose atropine. Started Sep 2022; status: completed.
02
Drugs
atropine
03
Conditions
myopia
Beyond the preview
Go deeper on TCTR20220930002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20220930002.